Monster Beverage vs Johnson & Johnson

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (78 vs 82)
Monster Beverage logo

Monster Beverage

LeaderConsumer Goods

Enterprise

US energy drink leader with $7.5B FY2024 revenue; Coca-Cola strategic partner (16.7% stake + global distribution); Bang acquisition 2023; competes with Celsius's fitness-focused challenger rise.

AI VisibilityBeta
Overall Score
B78
Category Rank
#48 of 347
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
80
Gemini
75

About

Monster Beverage Corporation is the world's leading energy drink company by market share in the United States, founded in 1935 as Hansen's Natural and rebranded to Monster Beverage in 2012, headquartered in Corona, California and trading on Nasdaq (MNST). The company generated approximately $7.5 billion in net sales for FY2024 under co-CEOs Hilton Schlosberg and Rob Sacks, with Monster Energy remaining the best-selling energy drink in the U.S. and the second globally behind Red Bull. A strategic partnership with Coca-Cola, which acquired a 16.7% stake in Monster in 2015 for approximately $2.15 billion and provides Monster with Coca-Cola's global distribution infrastructure, has been the foundational driver of Monster's international expansion across more than 150 countries.

Full profile
Johnson & Johnson logo

Johnson & Johnson

LeaderConsumer Goods

Health & Wellness

FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)

AI VisibilityBeta
Overall Score
A82
Category Rank
#19 of 347
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
77
Gemini
82

About

Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.

Full profile

AI Visibility Head-to-Head

78
Overall Score
82
#48
Category Rank
#19
82
AI Consensus
74
stable
Trend
stable
80
ChatGPT
83
80
Perplexity
77
75
Gemini
82
82
Claude
86
76
Grok
88

Key Details

Category
Enterprise
Health & Wellness
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Johnson & Johnson
Health & Wellness
Monster Beverage is classified as company. Johnson & Johnson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.